Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:June 15, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Hepatocellular CarcinomaLast Updated:June 15, 2023Not yet recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:January 10, 2024Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:January 3, 2019Unknown status
Condition(s):Hepatocellular CarcinomaLast Updated:August 31, 2023Completed
Condition(s):Hepatocellular CarcinomaLast Updated:February 4, 2021Recruiting
Condition(s):Microbiota; Hepatocellular Carcinoma; CirrhosisLast Updated:February 27, 2019Unknown status
Condition(s):Centrally Located Hepatocellular Carcinoma; Stereotactic Body Radiotherapy; HepatectomyLast Updated:February 6, 2023Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:April 16, 2015Terminated
Condition(s):Hepatocellular CarcinomaLast Updated:February 18, 2016Completed
Condition(s):Hepatocellular Carcinoma; Liver CirrhosisLast Updated:October 12, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.